Background-Data relating parental history of stroke to stroke risk in offspring remain surprisingly inconsistent, largely because of heterogeneity of study design and the absence of verified, as opposed to historical, data on parental stroke status. Methods and Results-We determined whether prospectively verified parental occurrence of stroke increased incident stroke risk among offspring in a community-based sample by studying 3443 stroke-free Framingham offspring (53% female; mean age, 48Ϯ14 years) with verified parental stroke status (by 65 years of age) who attended the first, third, fifth, and/or seventh offspring examinations and were followed up for up to 8 years after each baseline examination. Over up to 11 029 such person-observation periods (77 534 person-years), we documented 106 parental strokes by 65 years of age and 128 offspring strokes (74 parental and 106 offspring strokes were ischemic). Using multivariable Cox models adjusted for age, sex, sibship, and baseline stroke risk factors, we observed that parental stroke, both all stroke generally and ischemic stroke specifically, was associated with an increased risk of incident stroke of the same type in the offspring (hazard ratio, 2.79; 95% confidence interval, 1.68 to 4.66; PϽ0.001 for all stroke; and hazard ratio, 3.15; 95% confidence interval, 1.69 to 5.88; PϽ0.001 for ischemic stroke). This was true for both maternal and paternal stroke. Conclusions-Documented parental stroke by 65 years of age was associated with a 3-fold increase in risk of offspring stroke. This increased risk persisted after adjustment for conventional stroke risk factors. Thus, verified parental stroke may serve as a clinically useful risk marker of an individual's propensity to stroke. (Circulation. 2010;121:1304-1312.)
S
troke remains a leading cause of morbidity and mortality. Several environmental risk factors for stroke have been identified, but there is also a substantial heritable component to stroke risk. 1, 2 Several known monogenic disorders increase stroke risk and account for a familial aggregation within certain families; typically, these individuals develop stroke at a young age. 3 However, whereas parental coronary heart disease occurring at Ͻ60 years of age is accepted as a marker of increased coronary heart disease risk in the offspring, 4, 5 it has proved harder to definitively establish a genetic component for stroke risk in the general population, with surprising inconsistencies in published results. 6 -14 Results have ranged from a doubling of risk in the offspring 11 to no observed impact of parental history of stroke 15, 16 to an effect limited to certain age and sex groups, 6 an effect restricted to paternal stroke, 12, 14 or an effect confined to maternal stroke. 13 
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One reason for this variability in findings may be misclassification of parental stroke status. Prior studies examining the familial aggregation of stroke have used family history questionnaires administered to a proband, 8, [17] [18] [19] direct questioning of pedigree members, 20 or data from death certificates. 21 Each of these methods has significant limitations. Family history questionnaires underestimate stroke occurrence in family members; direct questioning of probands favors ascertainment of nonfatal over fatal stroke; and death certificate data underestimate the risk of nonfatal stroke. All 3 methods result in incorrect inclusion of some nonstroke events. 22 The Framingham study has the unique resource of directly verified data on stroke occurrence in both parents and offspring who belong to the Framingham original and offspring cohorts, respectively. The only previous investigation examining the verified occurrence of parental stroke (as opposed to a history of parental stroke) and the risk of offspring stroke was an earlier report from the Framingham study. 23 These analyses suggested the value of verified occurrence of stroke over a family history. There was no association between reported parental stroke death and the combined end point of incident stroke or transient ischemic attack (TIA) in original cohort participants, but there was a trend toward an association between verified parental stroke/ TIA in the original cohort and the risk of stroke/TIA in the offspring. However, the small number of stroke events available for analysis at the time of that initial report limited the power of that study, and the results failed to reach statistical significance. 23 Here, we reexamine and expand these prior analyses using the additional cases accrued since our previous report.
Familial aggregation may also vary by stroke subtype; therefore, studies that examined the heritability of all stroke (without classifying by stroke subtypes) may fail to detect a real familial aggregation. 24 The subtype of ischemic stroke (IS) is of greatest interest because it constitutes the largest proportion of total stroke burden in the population. Finally, risk may vary on the basis of the age at which the parental stroke occurred; some (but not all) studies have observed an increased risk only among individuals Ͻ65 or 70 years of age. 8,19,24 -27 In the present investigation, we prospectively assessed the relationship between parental occurrence of stroke by 65 years of age and risk of incident stroke in the offspring. We examined the risks associated with the specific subtypes of IS and atherothrombotic brain infarction (ABI) because they are the most common subtypes. Finally, we adjusted for the impact of traditional stroke risk factors that had been assessed systematically at each baseline evaluation of the Framingham original and offspring cohorts.
Methods

Study Sample and Design
The Framingham Heart Study is an ongoing prospective study of cardiovascular disease and its risk factors in an original ("parental") cohort of 5209 women and men 28 to 62 years of age at the time of enrollment in 1948. In 1971, the offspring of the original cohort and the spouses of these offspring (nϭ5124; age, 12 to 58 years; 3548 biological offspring, 1576 offspring spouses) were enrolled in the Framingham offspring cohort. These participants have been followed up every 4 years with the exception of the second examination cycle, which occurred 8 years after the first. The design of the Framingham Heart Study (original and offspring cohorts) and methods of risk factor measurements were described earlier. 28 -30 In the present investigation, Framingham offspring cohort participants free of prevalent stroke who attended the first, third, fifth, or seventh offspring examinations were followed up for up to 8 years or until the start of the next follow-up period; each such person-interval is called a person-observation period or simply an observation period. We used 8-year observation periods because parental stroke status and presence or absence of conventional stroke risk factors could vary between observation periods. However, the occurrence of stroke was ascertained in an ongoing, prospective manner, not just once every 8 years. 31 Offspring cohort participants who had Ն1 parents enrolled in the Framingham original cohort were included in our study if the enrolled parent either had sustained a prospectively identified and verified clinical stroke by 65 years of age or was known to be stroke free at this age. We chose this age cutoff to define parental stroke status as it had been proposed in previous studies. 8 The number of participants who were alive at the start of each baseline examination, the number attending each examination, and the number excluded (for absence of parental information, prevalent stroke at baseline, and lack of follow-up information on occurrence of incident stroke) are shown in Table 1 . Because the offspring cohort includes not only the biological children of the original cohort participants but also their spouses (whose parents may not have been enrolled in the Framingham original cohort), there is a substantial difference between the numbers who attended each baseline examination and those included in our study. We included a total of 3443 offspring who provided information over 11 029 observation periods (77 534 person-years). Risks were determined separately for persons in whom parental stroke status by 65 years of age was known in both parents (nϭ6633 observation periods, 46 517 person-years), in fathers only (nϭ8069 observation periods), and in mothers only (nϭ8473 observation periods). The parental information on these 3443 offspring was drawn from 2630 original cohort participants. This study was approved by the Institutional Review Board of the Boston Medical Center, and all subjects gave informed consent.
Definition of Outcomes
Stroke was defined as an acute-onset focal neurological deficit of presumed vascular origin persisting for Ն24 hours. All events were adjudicated by a panel of 2 neurologists. Details on stroke surveillance and the protocol for determining the final diagnosis, type, localization, and severity of stroke have been published; Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria 32 have been used since 1993, and events that occurred before 1993 have been reclassified using TOAST criteria whenever feasible. 33, 34 A TIA was defined as an episode of rapid-onset focal neurological dysfunction attributed to focal cerebral ischemia with resolution within 24 hours. Individual stroke subtypes were categorized on the standard diagnostic criteria and considered clinical features, imaging studies, and other laboratory data such as noninvasive vascular studies, cardiac assessment for possible embolic sources, and autopsy data when available. IS was diagnosed if a focal neurological deficit was documented and imaging showed no hemorrhage, imaging showed an ischemic infarct that correlated with the clinical deficit, or an ischemic infarct was documented at autopsy. ISs were further classified as ABIs if no cardiac source of embolus was found; this category included large-artery infarcts, lacunar infarcts, and infarcts of unknown origin.
Covariates
We adjusted our analysis for age, sex, and sibship among the offspring participants and for the covariates previously described as a part of the Framingham Stroke Risk Profile (FSRP). The covariates include age, sex, systolic blood pressure, antihypertensive therapy, diabetes mellitus, smoking status, history of cardiovascular disease other than stroke, and the presence of atrial fibrillation or left ventricular hypertrophy on the ECG (ECG-LVH). Risk factor data for the offspring cohort were gathered at the baseline offspring examination (first, third, fifth, or seventh) that marked the beginning of each person-observation period. For the original cohort, we used covariate data from the examination that the parent attended when he or she was closest to 50 years of age (Ϯ5 years). Current smoking was defined as cigarette smoking during the past year; the presence of diabetes mellitus was defined by a recorded fasting blood glucose Ͼ126 mg/dL (7 mmol/L), a previous diagnosis of diabetes mellitus, or the use of an antidiabetic drug or insulin. An average of 2 physician-recorded systolic blood pressure measurements was used. Previous cardiovascular disease events included a diagnosis of coronary heart disease, congestive heart failure, or peripheral vascular disease. The diagnosis of atrial fibrillation and ECG-LVH was based on consensus panel review of a standard 12-lead ECG obtained at the examination, data from a careful history at each study *Offspring participants whose father either developed a stroke by 65 years of age or was known to have survived up to 65 years of age free of stroke contributed person-observation periods to the analysis of risk associated with paternal stroke. Offspring participants whose mother either developed a stroke by 65 years of age or survived to 65 years of age free of stroke contributed person-observation periods to the analysis of risk associated with maternal stroke.
†A total of only 16 stroke events were not included in at least one of the many person-observation periods studied in these analyses. This row lists the number of persons (from among those attending the corresponding baseline examination) who were excluded for having a prevalent stroke at the start of that specific follow-up period. The stroke that led to their exclusion for this period had typically been included as an incident event in one of the previous person-observation periods for the same participant. We show in parentheses the number of persons who were excluded because they had a stroke event that was not included as an incident stroke in any prior observation period for that participant.
examination, and diligent tracking of all relevant medical records on each participant; however, the diagnosis may have been missed in some persons with paroxysmal atrial fibrillation.
Statistical Analysis
Participants were followed up until they developed the outcome of interest (stroke or TIA), died, or were lost to follow-up. Cox proportional-hazards models were used to determine the risk of incident offspring stroke over each observation period. Increased risk conferred by early parental occurrence of stroke was estimated after adjustment for age, sex, and sibship among offspring. We used generalized estimating equations to adjust for sibship and for the correlated nature of an individual's risk over several successive observation periods (model A). In secondary analyses, we adjusted for baseline stroke risk factors in the offspring (model B) and examined the association of parental stroke with early-onset stroke in the offspring occurring before 65 years of age (model C). We conducted analyses separately for maternal and paternal stroke, by stroke subtype in parent and offspring, and including TIA and completed strokes. We also studied the combined outcome of ABI and TIA because all ABI and most TIA share a common pathophysiological substrate of either large-artery thrombosis or small-artery occlusion, differing only in the duration of clinical symptoms. For the analyses of risk associated with parental (including both maternal and paternal) stroke, we required that stroke status information be available for both parents; for the analyses of the separate risks conferred by maternal and paternal stroke, we required only that information for that specific parent be available. For analyses assessing familial risk within stroke subtypes, participants who developed an alternative stroke subtype continued to be followed up for the development of IS. Finally, we examined the risks associated with parental stroke status within quintiles of baseline FSRP score in the offspring (model D). In tertiary exploratory analyses, we also examined these associations after additional adjustment for midlife (age, 50Ϯ5 years) parental stroke risk factors (model E) and within sex-specific offspring subgroups (model F).
Results
We directly documented 128 strokes (106 ischemic, 81 ABI) and 29 initial incident TIAs among the 3443 Framingham offspring participants in our study sample over a total of 11 029 observation periods. We had also prospectively identified or verified an incident clinical stroke by 65 years of age in 106 parents (74 ischemic, 55 ABI) and an initial incident TIA by 65 years of age in 22 parents. Of these, 50 strokes (35 ischemic, 30 ABI) and 2 isolated TIAs were in mothers and 56 strokes (39 ischemic, 25 ABI) and 20 TIAs were in fathers.
The distribution of baseline demographic and stroke risk factor characteristics in offspring with and without parental stroke by 65 years of age is summarized in Table 2 . Compared with offspring without parental stroke, offspring with verified parental stroke were younger, were more likely to be men, and had higher mean systolic blood pressure, greater use of antihypertensive medication, and a higher prevalence of diabetes mellitus, smoking, and ECG-LVH. Aggregate FSRP scores were also higher in the group with parental stroke. The prevalence of atrial fibrillation and prior cardiovascular disease did not differ between the 2 groups. Table 3 describes the midlife (age, 50Ϯ5 years) distribution of stroke risk factors in the parents. Table 4 describes the hazard ratios (HRs) for incident stroke by 65 years of age among offspring participants with parental stroke compared with offspring whose parents were documented to remain stroke free until 65 years of age (model A). The results are presented by subtype of parental and offspring stroke. Table 5 shows results after adjustment for baseline stroke risk factors in the offspring (model B), and Table 6 presents the risk of early offspring stroke occurring by 65 years of age (model C). We observed that offspring with documented parental history of any stroke type by 65 years of age had a 2-to 3-fold increased risk of stroke and that this risk was greatest for the subtype of ABI, although the risk was also increased for all stroke, IS, and the combined ABI and TIA categories of offspring stroke.
Adjustment for baseline levels of conventional stroke risk factors attenuated but did not abolish these associations. To assess whether the observed familial aggregation was restricted to offspring with a lower risk factor burden, we compared the cumulative incidence of stroke by 65 years of age within 5 subgroups of offspring participants grouped by 
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quintile of baseline FSRP score at the first, third, fifth, or seventh offspring examination (model D). The results are shown in the Figure. The higher risk in persons with parental stroke was seen across all quintiles of baseline FSRP score, with the greatest impact observed among persons in the highest quintile of stroke risk. Additional adjustment for midlife stroke risk factors in the parent (at 50 years of age) also did not abolish the observed association of parental and offspring stroke (model E; see Table I in the online-only Data Supplement). The relative risk (HR) associated with parental stroke was highest when we restricted our analyses to early stroke (occurring before 65 years of age) in the offspring. Thus, in analyses adjusted for baseline stroke risk factors, parental stroke by 65 years of age approximately doubled the risk of a stroke in the offspring (HR, 2.21; 95% confidence interval [CI], 1.32 to 3.70) but increased the risk of an offspring stroke before 65 years of age nearly 4-fold (HR, 3.79; 95% CI, 1.90 to 7.58).
Separate analyses were performed for paternal and maternal history of stroke; these results are presented in Tables 4  through 6 . Offspring with a positive paternal history of any stroke type had a 2-to 3-times greater risk of ever developing any stroke, IS, ABI, or a combined outcome of ABI and TIA and a 4-times greater risk of developing a stroke by 65 years of age. An increased risk was also associated with paternal IS, although the impact of paternal ABI or ABI and TIA on offspring stroke risk was less consistent, likely because of smaller numbers in the subgroup analyses. Maternal history of any stroke was again associated with a 2-to 3-fold increase in the risk of offspring strokes. This was true for any Offspring participants whose father either developed a stroke by 65 years of age or was known to have survived up to 65 years of age free of stroke contributed person-observation periods to the analysis of risk associated with paternal stroke. Offspring participants whose mother either developed a stroke by 65 years of age or survived to 65 years of age free of stroke contributed person-observation periods to the analysis of risk associated with maternal stroke. *PϽ0.05; †PϽ0.01; ‡PϽ0.001.
offspring stroke, for IS, ABI, or a combined outcome of ABI and TIA, but again the results were less consistent when we considered individual subtypes of maternal stroke. As observed for all parental strokes, the effects of paternal and maternal stroke on offspring stroke persisted after adjustment for baseline stroke risk factors in the offspring and were strongest when offspring risk of early-onset stroke was considered. In sex-specific analyses (model F), paternal stroke was related to the risk of offspring stroke in both men and women, whereas maternal stroke was significantly associated with the risk of offspring stroke in women but not in men (Table II in the online-only Data Supplement).
Discussion
In the 2-generation, community-based Framingham study cohort followed up prospectively for incident stroke and stroke risk factors over the past 4 decades, we observed that prospectively documented parental occurrence of stroke by 65 years of age was associated with a substantially increased risk of incident stroke in the offspring. This association was evident in analyses of all stroke and in analyses limited to individual stroke subtypes, being consistent across subgroups categorized by subtypes of parental or offspring stroke; subtypes assessed include IS, ABI, and ABI and TIA. The impact of parental stroke was greatest on the offspring risk of an early stroke occurring before 65 years of age, a finding consistent with previous studies. 8 The detection of a familial aggregation in stroke risk leaves unanswered the question of the relative contribution of shared genetic and environmental factors. Previous case-control and cohort studies examining the familial aggregation of stroke have been based largely on twin studies and sibpair analyses; there is a greater probability of confounding by shared environmental exposure in these studies. Observed associations of parental and offspring stroke have also been partly attributed to familial clustering of stroke risk factors such as hypertension and LVH. 25, 26, 35 In case-control studies, it is difficult to accurately determine the levels of stroke risk factors present before the event because measurements such as blood pressure may be altered by physiological consequences or pharmacological interventions after a stroke. The present analyses used the availability of stroke risk factor data that had been prospectively ascertained before the event to adjust for baseline stroke risk factors in the offspring and showed that the risk associated with parental stroke could not be attributed entirely to the inheritance and expression of baseline stroke risk factors such as hypertension in the offspring with parental stroke because the effect persisted after adjustment for stroke risk factor levels in the offspring. Moreover, the increased risk conferred by parental stroke Offspring participants whose father either developed a stroke by 65 years of age or was known to have survived up to 65 years of age free of stroke contributed person-observation periods to the analysis of risk associated with paternal stroke. Offspring participants whose mother either developed a stroke by 65 years of age or survived to 65 years of age free of stroke contributed person-observation periods to the analysis of risk associated with maternal stroke. *PϽ0.05; †PϽ0.01; ‡PϽ0.001.
status was observed at each quintile of offspring 10-year stroke risk as determined by the FSRP score. Our findings are consistent with prior studies reporting a marginally stronger association of paternal stroke (relative to maternal stroke) with offspring stroke. 12, 14 One prior report described a stronger association of maternal compared with paternal stroke with offspring stroke, 6 an observation that our study failed to confirm. One difference between the 2 studies is that Touze and Rothwell 6 questioned the proband to ascertain the occurrence of parental strokes, whereas stroke events were directly verified in the Framingham parental generation. It is possible that mothers may share their medical history, particularly with regard to transient events such as TIA, more readily with their offspring than fathers. In a previous report from the Framingham study examining the accuracy of offspring reports of parental cardiovascular disease, an offspring's report of maternal stroke had a greater sensitivity and positive predictive value than an offspring's report of paternal stroke. 22 Touze and Rothwell used a cross-sectional study design that may have detected the greater probability that women, with their higher life expectancy, would express an inherited propensity to stroke. Our study design, which used a survival analysis, is less likely to be affected by the difference in survival between women and men. Finally, Touze and Rothwell restricted their analysis to probands in whom parental stroke status was available for both mothers and fathers, 6 but repeating our analyses to exclude offspring with only 1 parent enrolled in the Framingham original cohort did not alter our results (data not presented). We did observe that the association between maternal and offspring stroke was stronger in female offspring compared with male offspring, which was in agreement with the results of a meta-analysis by the same authors. 7 The strengths of our study are the community-based sample, the prospective verification of both parental and Offspring participants whose father either developed a stroke by 65 years of age or was known to have survived up to 65 years of age free of stroke contributed person-observation periods to the analysis of risk associated with paternal stroke. Offspring participants whose mother either developed a stroke by 65 years of age or survived to 65 years of age free of stroke contributed person-observation periods to the analysis of risk associated with maternal stroke. *PϽ0.05; †PϽ0.01; ‡PϽ0.001. offspring stroke status, and the careful classification of stroke subtypes based on neurological examination, record review, and imaging. Furthermore, the impact of vascular risk factors could be accurately assessed because they had been systematically measured before the stroke both in the parents and in the offspring. Limitations of this study include the overwhelmingly European origin of the study sample and the limited number of events among individual stroke subtypes, which restricted our ability to conduct separate subgroup analyses for stroke subtypes of cardioembolic and lacunar strokes, although the latter was included in the category of atherothrombotic strokes. Finally, we did not adjust for newer stroke risk factors such as plasma homocysteine and C-reactive protein levels. It remains possible that the observed aggregation may be attributable to familial aggregation of unidentified environmental, behavioral, and lifestylerelated factors.
Of particular preventive interest, although family history or familial occurrence of stroke is appropriately considered to be a nonmodifiable risk factor for stroke, we find that the level of conventional risk factors amplifies the increased stroke risk associated with a positive family history, particularly in the top quintile of the FSRP (the Figure) . Thus, attention to control of modifiable risk factors for stroke prevention, particularly in the presence of a positive familial occurrence (or history) of premature stroke, is strongly supported by these data.
Nevertheless, the demonstrated strong association of parental and offspring strokes and the particularly strong demonstrable association between IS in parent and offspring suggest that there is indeed a substantial genetic contribution to the risk of all stroke and IS. This is unlikely to be due to shared environmental factors alone because the increased risk persisted after adjustment for levels of conventional stroke risk factors. Candidate gene studies 36 and more recently genome-wide association analyses 37, 38 have identified several putative genes that may underlie this genetic propensity. It is probable that there are genes that increase the risk of all stroke types and other genes that specifically increase the risk of IS and IS subtypes. The Framingham study is currently relating 550K genome-wide association data to the risk of incident stroke; the observed strong familial aggregation suggests that such efforts should prove fruitful. Finally, the 3-fold independent increase in risk associated with premature parental stroke (by 65 years of age in our study) suggests that this simple measure might prove to be a useful risk marker in clinical risk prediction. Parental stroke status and age of parent at stroke may be measures worth incorporating into future revisions of the Framingham and other stroke risk prediction algorithms.
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